from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3286c/sigF

LFCtreatmentdescriptionclass of inhibitor

0.616

Amikacinug/mL Amikacintranslation

-0.687

Cap5-10ug/mL Capreomycintranslation

0.027

Rox10-50 ug/mL Roxithromycintranslation

0.346

SM2-5 ug/mL Streptomycintranslation

0.885

Tet5-10 ug/mL Tetracyclinetranslation

1.789

Rif0.2-5ug/mL Rifampicintranscription

0.116

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.160

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.305

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.332

CPZ10-50 ug/mL Chlorpromazinerespiration

1.354

Clofazimine10-13 ug/mL Clofaziminerespiration

0.273

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.577

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.689

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.465

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.346

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.307

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.717

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.185

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.526

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.873

KCN5-20 ug/mL Potassium cyaniderespiration

-0.333

NaN30.2-2 mM Sodium aziderespiration

-0.889

Nigericin50 uM Nigericinrespiration

0.842

TRC10-150 ug/mL Triclosanrespiration

1.082

TRZ10-25 ug/mL Thioridazinerespiration

-0.016

Valinomycin0.5-10 uM Valinomycinrespiration

-1.160

ZnSO42 mM ZnSO4respiration

-0.921

menadione6-10 ug/mL Menadionerespiration

-0.263

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.767

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.858

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.252

NRP_1Non-replicating persistence stage 1dosRassociated

0.430

Amp0.2mg/mL AmpicillincellWall

-0.205

Cephalexin20-100 ug/mL CephalexincellWall

-0.906

Cerulenin0.32-5 ug/mL CerulenincellWall

0.463

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.475

EMB10-20 ug/mL EthambutolcellWall

0.070

Eta12-40 ug/mL EthionamidecellWall

-0.058

INH0.2-0.4 ug/mL IsoniazidcellWall

0.599

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.917

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.509

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.145

BZA0.12 mg/mL BenzamidearomaticAmides

-0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.538

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.505

H2O24 mM hydrogen peroxideDNAdamaging

-0.190

Levo10 ug/mL LevofloxacinDNAdamaging

-0.234

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.333

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.597

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.449

UVUV-irradiationDNAdamaging

1.634

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.028

Antimycin12.5-50 ug/mL Antimycin A?

-0.289

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.262

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.822

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.221

PA8240.2-2 ug/mL PA-824?

0.316

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.243

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.009

Verapamil50 uM Verapamil?

-0.744

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.092

methoxatin10-20 ug/mL Methoxatin?